SEngine Precision Medicine Inc. is a precision oncology company revolutionizing cancer diagnostics and therapies by pre-testing drugs on patient-derived organoids grown ex-vivo utilizing patient ...

OYE has repurposed and reformulated a injectable drug product that accelerates emergence from anesthesia roughly 50% faster than the current standard of care. The downstream impact of the intervention ...

Thank you for downloading the BIO Membership Brochure! You can access the brochure below, and we will also send you a copy via email to keep for your records and pass along to your colleagues. If you ...

This is the only conference focused specifically on intellectual property in biotechnology, featuring the latest insights from biotech IP experts, as well as networking events designed to promote ...

BIO President & CEO John F. Crowley released the following statement: “A healthy and prosperous society is vitally important to the American people and to the world. The public health, economic ...

BIO strongly supports a manufacturer’s ability to use a 340B rebate as an appropriate option to make 340B pricing available to covered entities. "Manufacturers should have the choice to effectuate ...

WASHINGTON – BIO President & CEO John F. Crowley released the following statement on the results of the 2024 U.S. election: “We look forward to working closely with President-elect Trump, his incoming ...

Biotechnology is bringing us climate-smart technologies to recycle carbon, reduce greenhouse gas emissions and strengthen the resilience of agriculture and food production. Explore the resources and ...

Today, we explore BIO’s recommendations for how CMS can safeguard patient access under Medicare Part D, along with insights on a California Supreme Court case that could affect the complex drug ...

At its simplest, biotechnology is technology based on biology - biotechnology harnesses cellular and biomolecular processes to develop technologies and products that help improve our lives and the ...

A collaborative initiative to advance corporate board diversity through partnerships and more.

Explore the webinar opportunities for interactive, online learning about emerging issues in biotechnology public policy, scientific progress, and raising capital, plus methods to benefit from BIO’s ...